Original Research
Published on 12 Jun 2023
Deletion of Miro1 in airway club cells potentiates allergic asthma phenotypes
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2023.1187945
- 2,235 views
- Frontiers in Allergy
- Asthma
- Articles
Type at least 3 characters
75 articles
Articles
Original Research
Published on 06 Jun 2023
GliSODin® prevents airway inflammation by inhibiting T-cell differentiation and activation in a mouse model of asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2023.1199355
- 2,621 views
Review
Published on 30 May 2023
The role of the respiratory microbiome in asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2023.1120999
- 6,144 views
- 15 citations
Original Research
Published on 23 May 2023
High-fat diet and palmitic acid amplify airway type 2 inflammation
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2023.1193480
- 2,116 views
- 6 citations
Editorial
Published on 05 Apr 2023
Editorial: Airway remodeling in asthma—what is new?
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2023.1129840
- 1,198 views
Correction
Published on 10 Jan 2023
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1119941
- 1,076 views
Brief Research Report
Published on 04 Jan 2023
Real-World clinical outcomes of asthma patients switched from reslizumab to mepolizumab or benralizumab
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1052339
- 2,077 views
Original Research
Published on 25 Nov 2022
IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1062412
- 3,468 views
- 7 citations
Mini Review
Published on 17 Nov 2022
Paroxysmal dyspnoea in asthma: Wheeze, ILO or dysfunctional breathing?
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1054791
- 2,815 views
- 4 citations
Perspective
Published on 14 Nov 2022
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.1007593
- 4,330 views
- 3 citations
Review
Published on 21 Oct 2022
Asthma in elite athletes – do they have Type 2 or non-Type 2 disease? A new insight on the endotypes among elite athletes
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.973004
- 5,984 views
- 3 citations
Original Research
Published on 30 Sep 2022
Exercise-induced bronchoconstriction in university field hockey athletes: Prevalence, sex differences, and associations with dyspnea symptoms
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.994947
- 1,741 views
- 1 citation
Review
Published on 20 Sep 2022
Role of airway epithelial cell miRNAs in asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.962693
- 2,765 views
- 5 citations
Review
Published on 15 Sep 2022
Airway remodeling: The Drosophila model permits a purely epithelial perspective
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.876673
- 4,373 views
- 8 citations
Review
Published on 12 Sep 2022
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.993937
- 2,223 views
- 2 citations
Review
Published on 11 Aug 2022
What is the added value of FeNO as T2 biomarker?
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2022.957106
- 5,976 views
- 9 citations